A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

Filer Snapshot

Caligan Partners LP SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001727492.

Entity Type

Company

Total Filings

124

Latest Filing

20 May 2026

Industry

n/a

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

Use the filings table to verify the newest submission, form type, and report period.
Open the deeper context page only when this filer actually has insider or ownership signal.

Go to latest filings table Open reporting owner context

Source: SEC Forms 3/4/5

4 filed on 20 May 2026 for CIK 0001727492.

View Source Filing

Business address: 780 Third Avenue, 30 Th Floor, New York, NY, 10017
Top holdings (ownership): LQDA, LAB, and VRCA
Top securities (13F): LQDA, ABVX, RVMD, PCVX, XENE, MLYS, EXEL, TNGX, TYRA, SYRE, ADMA, LBRX, VOR, SABS, IRD, IVA, MBX, AVTX, ANIK, and MAZE
Top holdings (Schedule 13D): VRCA and ANIK
Top holdings (Schedule 13G): LBRX, EOLS, SABS, IRD, AVTX, YMAB, VRCA, and SNSE
State of incorporation: DE
Fiscal year end: 31 December

Key facts

Caligan Partners LP is an SEC filer tracked under CIK 0001727492.
124 filings are listed on this profile.
Common form coverage includes 4, SCHEDULE 13G, SCHEDULE 13G/A and more.

Change

Latest filing: 4 filed on 20 May 2026.
Report period: 19 May 2026.

Research use

You can quote filing dates and form types directly from the SEC record on this page.
Use this profile before deeper ownership or insider analysis to confirm filing history context.

Evidence

Source: SEC Forms 3/4/5

4 filed on 20 May 2026 for CIK 0001727492.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed 4 can change the filing history, ownership context, or next research path for Caligan Partners LP.

Latest source-backed update: 4 filed 20 May 2026
Why come back: Revisit after a new SEC filing appears to compare the updated record with prior filings.

Latest filing on record: 4 filed 20 May 2026.
Save this filer if you want a stable place to return after the next filing cycle.
Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Jump to save and follow actions Open latest filings table

Latest update

What changed recently for Caligan Partners LP

Ownership report updated

Latest ownership report period: 19 May 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

20 May 2026

Page type

Ownership filings

Latest period

19 May 2026

Ownership context was refreshed from SEC Forms 3/4/5 filed on 20 May 2026.

Open ownership filings Browse recent public updates

Benchmark Context

Benchmark context for this company

Caligan Partners LP has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest ownership report period: 19 May 2026. That gives you a fresh baseline before you compare this company with peers.

Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

Company intelligence

Caligan Partners LP: filings, ownership, insiders

CIK 0001727492. Open the active data lane, then verify the SEC filing behind the row.

Create free account to watch this company Open ownership signals

Active modules

3/5

Available company intelligence paths on this page.

Filings

124

SEC submissions provide the evidence trail.

Ownership context

2/3

Insider, large-stake, and institutional ownership lanes.

Return loop

Watch

Return when a new SEC-backed change lands.

Research checks

Latest filing

4 filed 20 May 2026

Ownership lanes

2/3 active

CIK

0001727492

Next review

watch new filing, insider, 13D/G, or 13F change

SEC-verifiable company research path

Keep the next click tied to one changing object: a CIK, filing, insider, Schedule 13D/G holder, Form 13F manager, or security.

Open latest insider signals Open large-stake radar

SEC filings

Available

Latest company filings

Start with the filing timeline to verify the newest source document and report period.

Open filings table

Company facts

Explore

Financial context

Use XBRL facts when ownership activity needs revenue, earnings, debt, or cash-flow context.

Browse latest financial reports

Forms 3/4/5

Explore

Insider activity

Check whether directors, officers, or 10% owners are buying, selling, or filing fresh ownership changes.

Browse latest insider filings

Schedule 13D/G

Available

Large-stake holders

Review beneficial ownership filings for activist-style or passive large holder changes around this issuer.

Open 13D/G history

Form 13F

Available

Institutional holders

Compare manager filings and smart-money context when company-level ownership needs broader holders.

Open 13F holder context

SEC-verifiable company hub

Filings first, then ownership signals, insider context, and fundamentals.

Create free account to watch this company

Watchlist return triggers

Watch Caligan Partners LP when any filing-backed ownership signal appears, then jump back into the exact SEC evidence path.

new company filing insider Form 4 13D/G holder change 13F holder update

Filer Overview

Caligan Partners LP has filed 124 SEC EDGAR filings since 11 Mar 2019. Common forms include 4, SCHEDULE 13G, SCHEDULE 13G/A, 13F-HR and more.

Caligan Partners LP SEC filings Caligan Partners LP 13F portfolio Caligan Partners LP 13D/G history Caligan Partners LP owner filings

Latest Filings

Recent SEC filings for Caligan Partners LP with direct links to document and filing folders.

4 File 001-39724

4 filing

Filing date: 20 May 2026
Reporting date: 19 May 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G

SCHEDULE 13G filing

Filing date: 15 May 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G

SCHEDULE 13G filing

Filing date: 15 May 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G

SCHEDULE 13G filing

Filing date: 15 May 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date: 15 May 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 15 May 2026
Reporting date: 31 Mar 2026
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G

SCHEDULE 13G filing

Filing date: 15 May 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date: 17 Feb 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 17 Feb 2026
Reporting date: 31 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date: 17 Feb 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date: 27 Jan 2026
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date: 30 Dec 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3 File 001-38529

3 filing

Filing date: 30 Dec 2025
Reporting date: 26 Dec 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 000-30235

4 filing

Filing date: 26 Nov 2025
Reporting date: 25 Nov 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13D

SCHEDULE 13D filing

Filing date: 24 Nov 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13D/A

SCHEDULE 13D/A filing

Filing date: 21 Nov 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 14 Nov 2025
Reporting date: 30 Sep 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date: 14 Nov 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G

SCHEDULE 13G filing

Filing date: 14 Nov 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G/A

SCHEDULE 13G/A filing

Filing date: 14 Nov 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

N-PX File 028-23096

N-PX filing

Filing date: 02 Sep 2025
Reporting date: 30 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 14 Aug 2025
Reporting date: 30 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G

SCHEDULE 13G filing

Filing date: 14 Aug 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-39724

4 filing

Filing date: 20 Jun 2025
Reporting date: 17 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 000-30235

4 filing

Filing date: 02 Jun 2025
Reporting date: 29 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 15 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G

SCHEDULE 13G filing

Filing date: 14 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 14 Feb 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SCHEDULE 13G

SCHEDULE 13G filing

Filing date: 12 Feb 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 14 Nov 2024
Reporting date: 30 Sep 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34703

4 filing

Filing date: 18 Sep 2024
Reporting date: 16 Sep 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

ALIMERA SCIENCES, INC.

Filing date: 18 Sep 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-39724

4 filing

Filing date: 12 Sep 2024
Reporting date: 12 Sep 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

LIQUIDIA CORP

Filing date: 12 Sep 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

LIQUIDIA CORPORATION

Filing date: 04 Sep 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-39724

4 filing

Filing date: 04 Sep 2024
Reporting date: 30 Aug 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

N-PX File 028-23096

N-PX filing

Filing date: 30 Aug 2024
Reporting date: 30 Jun 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 14 Aug 2024
Reporting date: 30 Jun 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-39724

OWNERSHIP DOCUMENT

Filing date: 24 Jun 2024
Reporting date: 20 Jun 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

ALIMERA SCIENCES, INC.

Filing date: 24 Jun 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 000-30235

4 filing

Filing date: 04 Jun 2024
Reporting date: 31 May 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 000-30235

4 filing

Filing date: 30 May 2024
Reporting date: 28 May 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

ANIKA THERAPEUTICS, INC.

Filing date: 30 May 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 13 May 2024
Reporting date: 31 Mar 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

ANIKA THERAPEUTICS, INC.

Filing date: 06 Mar 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 000-30235

4 filing

Filing date: 22 Feb 2024
Reporting date: 21 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 14 Feb 2024
Reporting date: 31 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

STANDARD BIOTOOLS, INC.

Filing date: 08 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-39724

4 filing

Filing date: 14 Dec 2023
Reporting date: 14 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

LIQUIDIA CORPORATION

Filing date: 14 Dec 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 000-30235

4 filing

Filing date: 29 Nov 2023
Reporting date: 27 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 14 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34703

4 filing

Filing date: 15 Sep 2023
Reporting date: 14 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

ANIKA THERAPEUTICS, INC.

Filing date: 11 Sep 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34703

4 filing

Filing date: 17 Aug 2023
Reporting date: 15 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D

ANIKA THERAPEUTICS, INC.

Filing date: 17 Aug 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 14 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3 File 001-34703

3 filing

Filing date: 11 Aug 2023
Reporting date: 01 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

ALIMERA SCIENCES, INC.

Filing date: 03 Aug 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34180

4 filing

Filing date: 03 Jul 2023
Reporting date: 29 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

STANDARD BIOTOOLS, INC.

Filing date: 03 Jul 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-39724

4 filing

Filing date: 21 Jun 2023
Reporting date: 19 Jun 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 000-30235

4 filing

Filing date: 02 Jun 2023
Reporting date: 31 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

3 File 000-30235

3 filing

Filing date: 02 Jun 2023
Reporting date: 31 May 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

EXELIXIS, INC.

Filing date: 02 Jun 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

ALIMERA SCIENCES, INC.

Filing date: 18 May 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR/A File 028-23096

13F-HR/A filing

Filing date: 15 May 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 15 May 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 06 Apr 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PRRN14A

ANIKA THERAPEUTICS, INC.

Filing date: 06 Apr 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PREC14A

ANIKA THERAPEUTICS, INC.

Filing date: 30 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

ALIMERA SCIENCES, INC.

Filing date: 28 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

EXELIXIS, INC.

Filing date: 27 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D

EXELIXIS, INC.

Filing date: 20 Mar 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DFAN14A

ANIKA THERAPEUTICS, INC.

Filing date: 21 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

13F-HR File 028-23096

13F-HR filing

Filing date: 15 Feb 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34180

4 filing

Filing date: 30 Dec 2022
Reporting date: 29 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

STANDARD BIOTOOLS INC.

Filing date: 30 Dec 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

ADMA BIOLOGICS, INC.

Filing date: 09 Dec 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-39724

4 filing

Filing date: 07 Sep 2022
Reporting date: 06 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

SC 13D/A filing

Filing date: 05 Aug 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34180

4 filing

Filing date: 05 Aug 2022
Reporting date: 03 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34180

4 filing

Filing date: 02 Aug 2022
Reporting date: 29 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34180

4 filing

Filing date: 15 Jun 2022
Reporting date: 13 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

STANDARD BIOTOOLS, INC.

Filing date: 07 Jun 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34180

4 filing

Filing date: 06 Jun 2022
Reporting date: 02 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-39724

4 filing

Filing date: 26 May 2022
Reporting date: 25 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D

ALIMERA SCIENCES, INC.

Filing date: 25 May 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-39724

4 filing

Filing date: 19 May 2022
Reporting date: 17 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34180

4 filing

Filing date: 10 May 2022
Reporting date: 06 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

STANDARD BIOTOOLS, INC.

Filing date: 03 May 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34180

4 filing

Filing date: 02 May 2022
Reporting date: 28 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-39724

4 filing

Filing date: 18 Apr 2022
Reporting date: 18 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34180

4 filing

Filing date: 13 Apr 2022
Reporting date: 11 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-34180

4 filing

Filing date: 08 Apr 2022
Reporting date: 06 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

FLUIDIGM CORPORATION

Filing date: 29 Mar 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D

ADMA BIOLOGICS, INC.

Filing date: 04 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

LIQUIDIA CORPORATION

Filing date: 07 Dec 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D

FLUIDIGM CORPORATION

Filing date: 10 May 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3 File 001-34180

3 filing

Filing date: 10 May 2021
Reporting date: 07 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3 File 001-39724

3 filing

Filing date: 15 Apr 2021
Reporting date: 12 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D

LIQUIDIA CORPORATION

Filing date: 15 Apr 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4 File 001-10865

4

Filing date: 17 Nov 2020
Reporting date: 16 Nov 2020
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

AMAG PHARMACEUTICALS, INC.

Filing date: 16 Nov 2020
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

AMAG PHARMACEUTICALS, INC.

Filing date: 10 Oct 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

KNOWLES CORP

Filing date: 30 Sep 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DFRN14A

AMAG PHARMACEUTICALS, INC.

Filing date: 26 Sep 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DFAN14A

AMAG PHARMACEUTICALS, INC.

Filing date: 26 Sep 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DFAN14A

AMAG PHARMACEUTICALS, INC.

Filing date: 16 Sep 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DFAN14A

DFAN14A filing

Filing date: 16 Sep 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFC14A

AMAG PHARMACEUTICALS, INC.

Filing date: 16 Sep 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DFAN14A

AMAG PHARMACEUTICALS, INC.

Filing date: 04 Sep 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

AMAG PHARMACEUTICALS, INC.

Filing date: 04 Sep 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PREC14A

AMAG PHARMACEUTICALS, INC.

Filing date: 04 Sep 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3 File 001-10865

3 filing

Filing date: 15 Aug 2019
Reporting date: 12 Aug 2019
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D

AMAG PHARMACEUTICALS, INC.

Filing date: 15 Aug 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A

KNOWLES CORP

Filing date: 09 May 2019
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DFAN14A